The ubiquitin-proteasome system (UPS) is highly complex and entails the concerted actions of many enzymes that function to ubiquitinate proteins targeted to the proteasome as well as enzymes that remove and recycle ubiquitin for additional rounds of proteolysis. Ubiquitin C-terminal hydrolase-L3 (UCH-L3) is a human cytosolic deubiquitinase whose precise biological function is not known. It is believed to hydrolyze small peptides or chemical adducts from the C-terminus of ubiquitin that may be remnant from proteasomal processing. In addition, UCH-L3 is a highly effective biotechnological tool that is used to produce small or unstable peptides/proteins recalcitrant to production in Escherichia coli expression systems. Previous research, which explored the substrate selectivity of UCH-L3, demonstrated a substrate size limitation for proteins/peptides expressed as α-linked C-terminal fusions to ubiquitin and also suggested that an additional substrate property may affect UCH-L3 hydrolysis [ Larsen , C. N. et al. (1998) Biochemistry 37 , 3358 - 3368 ]. Using a series of engineered protein substrates, which are similar in size yet differ in secondary structure, we demonstrate that thermal stability is a key factor that significantly affects UCH-L3 hydrolysis. In addition, we show that the thermal stabilities of the engineered substrates are not altered by fusion to ubiquitin and offer a possible mechanism as to how ubiquitin affects the structural and unfolding properties of natural in vivo targets.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/bi5006317 | DOI Listing |
Heliyon
December 2024
Wageningen Food Safety Research, Akkermaalsbos 2, P.O. box 230, 3700 AE, Wageningen, the Netherlands.
Insects are increasingly used as an alternative protein source for feed and food production. One of the main biological hazards associated with edible insects is the bio-accumulation of foodborne pathogenic microorganisms. In this study, the interaction of larvae of the black soldier fly (BSFL, (L.
View Article and Find Full Text PDFFood Chem X
January 2025
Department of Horticultural Science, National Chiayi University, Chiayi 60004, Taiwan.
Specialty coffee, typically lightly roasted, is valued for its unique fruity aroma. However, the fermentation process poses a risk of contamination with ochratoxin-producing fungi. This study aimed to select wild yeast strains capable of contributing distinctive flavor profiles while inhibiting the growth of ochratoxin-producing fungi.
View Article and Find Full Text PDFNano Lett
January 2025
School of Optical and Electronic Information, Wuhan National Laboratory for Optoelectronics, Huazhong University of Science and Technology, Wuhan 430074, China.
Achieving high flexibility, breathability, and sensitivity in inorganic semiconductor gas sensors remains a substantial challenge, especially for wearable applications in high-humidity environments. This study develops a hyper-flexible, thermally stable, and highly breathable full-inorganic, self-supporting InGaO-AlO/AlO nanofiber membrane sensor, fabricated using a dual-spinneret electrospinning method with an interlocking design. This innovative sensor has a bilayer structure with an amorphous AlO nanofiber substrate layer supporting an active layer of high-aspect-ratio interwoven InGaO and AlO nanofibers, providing outstanding flexibility, elevated breathability, and strong thermal stability.
View Article and Find Full Text PDFBiotechnol Bioeng
January 2025
School of Energy Science and Engineering, Indian Institute of Technology Kharagpur, Kharagpur, West Bengal, India.
Microbial communities have shown promising potential in degrading complex biopolymers, producing value-added products through collaborative metabolic functionality. Hence, developing synthetic microbial consortia has become a predominant technique for various biotechnological applications. However, diverse microbial entities in a consortium can engage in distinct biochemical interactions that pose challenges in developing mutualistic communities.
View Article and Find Full Text PDFYakugaku Zasshi
January 2025
Department of Personalized Medicine and Preventive Healthcare Sciences, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University.
Notable advances have recently been achieved in drug therapies for renal cell carcinoma (RCC). Several tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) have been approved for metastatic RCC (mRCC). The current first-line treatment for mRCC involves combination therapies using TKIs and ICIs.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!